315 related articles for article (PubMed ID: 26972631)
1. Relations of circulating GDF-15, soluble ST2, and troponin-I concentrations with vascular function in the community: The Framingham Heart Study.
Andersson C; Enserro D; Sullivan L; Wang TJ; Januzzi JL; Benjamin EJ; Vita JA; Hamburg NM; Larson MG; Mitchell GF; Vasan RS
Atherosclerosis; 2016 May; 248():245-51. PubMed ID: 26972631
[TBL] [Abstract][Full Text] [Related]
2. GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD.
Tuegel C; Katz R; Alam M; Bhat Z; Bellovich K; de Boer I; Brosius F; Gadegbeku C; Gipson D; Hawkins J; Himmelfarb J; Ju W; Kestenbaum B; Kretzler M; Robinson-Cohen C; Steigerwalt S; Bansal N
Am J Kidney Dis; 2018 Oct; 72(4):519-528. PubMed ID: 29866459
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers of cardiovascular stress and incident chronic kidney disease.
Ho JE; Hwang SJ; Wollert KC; Larson MG; Cheng S; Kempf T; Vasan RS; Januzzi JL; Wang TJ; Fox CS
Clin Chem; 2013 Nov; 59(11):1613-20. PubMed ID: 23873716
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers of cardiovascular stress and subclinical atherosclerosis in the community.
Gopal DM; Larson MG; Januzzi JL; Cheng S; Ghorbani A; Wollert KC; Kempf T; D'Agostino RB; Polak JF; Ramachandran VS; Wang TJ; Ho JE
Clin Chem; 2014 Nov; 60(11):1402-8. PubMed ID: 25237063
[TBL] [Abstract][Full Text] [Related]
5. Associations of Circulating Growth Differentiation Factor-15 and ST2 Concentrations With Subclinical Vascular Brain Injury and Incident Stroke.
Andersson C; Preis SR; Beiser A; DeCarli C; Wollert KC; Wang TJ; Januzzi JL; Vasan RS; Seshadri S
Stroke; 2015 Sep; 46(9):2568-75. PubMed ID: 26219649
[TBL] [Abstract][Full Text] [Related]
6. Association of Growth Differentiation Factor 15 with Arterial Stiffness and Endothelial Function in Subpopulations of Patients with Coronary Artery Disease: A Proof-of-Concept Study.
Mourouzis K; Siasos G; Bozini N; Oikonomou E; Zaromitidou M; Tsigkou V; Kokkou E; Bletsa E; Stampouloglou P; Vavuranakis M; Tousoulis D
Recent Adv Inflamm Allergy Drug Discov; 2022; 16(2):107-115. PubMed ID: 36336806
[TBL] [Abstract][Full Text] [Related]
7. Increased Plasma Concentrations of Soluble ST2 Independently Predict Mortality but not Cardiovascular Events in Stable Coronary Heart Disease Patients: 13-Year Follow-up of the KAROLA Study.
Pfetsch V; Sanin V; Jaensch A; Dallmeier D; Mons U; Brenner H; Koenig W; Rothenbacher D
Cardiovasc Drugs Ther; 2017 Apr; 31(2):167-177. PubMed ID: 28283847
[TBL] [Abstract][Full Text] [Related]
8. High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study.
Jia X; Sun W; Hoogeveen RC; Nambi V; Matsushita K; Folsom AR; Heiss G; Couper DJ; Solomon SD; Boerwinkle E; Shah A; Selvin E; de Lemos JA; Ballantyne CM
Circulation; 2019 Jun; 139(23):2642-2653. PubMed ID: 31030544
[TBL] [Abstract][Full Text] [Related]
9. Relation between soluble ST2, growth differentiation factor-15, and high-sensitivity troponin I and incident atrial fibrillation.
Rienstra M; Yin X; Larson MG; Fontes JD; Magnani JW; McManus DD; McCabe EL; Coglianese EE; Amponsah M; Ho JE; Januzzi JL; Wollert KC; Fradley MG; Vasan RS; Ellinor PT; Wang TJ; Benjamin EJ
Am Heart J; 2014 Jan; 167(1):109-115.e2. PubMed ID: 24332149
[TBL] [Abstract][Full Text] [Related]
10. A comparative analysis of novel cardiovascular biomarkers in patients with chronic heart failure.
Lichtenauer M; Jirak P; Wernly B; Paar V; Rohm I; Jung C; Schernthaner C; Kraus J; Motloch LJ; Yilmaz A; Hoppe UC; Christian Schulze P; Kretzschmar D; Pistulli R
Eur J Intern Med; 2017 Oct; 44():31-38. PubMed ID: 28579310
[TBL] [Abstract][Full Text] [Related]
11. Cardiac and Stress Biomarkers and Chronic Kidney Disease Progression: The CRIC Study.
Bansal N; Zelnick L; Shlipak MG; Anderson A; Christenson R; Deo R; deFilippi C; Feldman H; Lash J; He J; Kusek J; Ky B; Seliger S; Soliman EZ; Go AS;
Clin Chem; 2019 Nov; 65(11):1448-1457. PubMed ID: 31578216
[TBL] [Abstract][Full Text] [Related]
12. Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseases.
Mueller T; Leitner I; Egger M; Haltmayer M; Dieplinger B
Clin Chim Acta; 2015 May; 445():155-60. PubMed ID: 25850080
[TBL] [Abstract][Full Text] [Related]
13. Association of subclinical myocardial injury with arterial stiffness in patients with type 2 diabetes mellitus.
Yiu KH; Zhao CT; Chen Y; Siu CW; Chan YH; Lau KK; Liu S; Lau CP; Tse HF
Cardiovasc Diabetol; 2013 Jun; 12():94. PubMed ID: 23799879
[TBL] [Abstract][Full Text] [Related]
14. Head-to-head comparison of serial soluble ST2, growth differentiation factor-15, and highly-sensitive troponin T measurements in patients with chronic heart failure.
Gaggin HK; Szymonifka J; Bhardwaj A; Belcher A; De Berardinis B; Motiwala S; Wang TJ; Januzzi JL
JACC Heart Fail; 2014 Feb; 2(1):65-72. PubMed ID: 24622120
[TBL] [Abstract][Full Text] [Related]
15. The utility of growth differentiation factor-15, galectin-3, and sST2 as biomarkers for the diagnosis of heart failure with preserved ejection fraction and compared to heart failure with reduced ejection fraction: a systematic review.
Rabkin SW; Tang JKK
Heart Fail Rev; 2021 Jul; 26(4):799-812. PubMed ID: 32472523
[TBL] [Abstract][Full Text] [Related]
16. Association of Soluble Suppression of Tumorigenesis-2 (ST2) with Endothelial Function in Patients with Ischemic Heart Failure.
Dimitropoulos S; Mystakidi VC; Oikonomou E; Siasos G; Tsigkou V; Athanasiou D; Gouliopoulos N; Bletsa E; Kalampogias A; Charalambous G; Tsioufis C; Vavuranakis M; Tousoulis D
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33317161
[TBL] [Abstract][Full Text] [Related]
17. Predictive Properties of Biomarkers GDF-15, NTproBNP, and hs-TnT for Morbidity and Mortality in Patients With Type 2 Diabetes With Nephropathy.
Bidadkosh A; Lambooy SPH; Heerspink HJ; Pena MJ; Henning RH; Buikema H; Deelman LE
Diabetes Care; 2017 Jun; 40(6):784-792. PubMed ID: 28341782
[TBL] [Abstract][Full Text] [Related]
18. Association of circulating growth differentiation factor-15, Krüppel-like factor 4 and growth arrest-specific 6 with coronary artery disease.
Liu H; Lyu YN; Li D; Cui Y; Dai W; Li Y
Clin Chim Acta; 2019 Aug; 495():630-636. PubMed ID: 31153870
[TBL] [Abstract][Full Text] [Related]
19. GDF-15 is a better complimentary marker for risk stratification of arrhythmic death in non-ischaemic, dilated cardiomyopathy than soluble ST2.
Stojkovic S; Kaider A; Koller L; Brekalo M; Wojta J; Diedrich A; Demyanets S; Pezawas T
J Cell Mol Med; 2018 Apr; 22(4):2422-2429. PubMed ID: 29397580
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers for characterization of heart failure - Distinction of heart failure with preserved and reduced ejection fraction.
Sinning C; Kempf T; Schwarzl M; Lanfermann S; Ojeda F; Schnabel RB; Zengin E; Wild PS; Lackner KJ; Munzel T; Blankenberg S; Wollert KC; Zeller T; Westermann D
Int J Cardiol; 2017 Jan; 227():272-277. PubMed ID: 27838133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]